Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy

Toxicology

Volumn 264, Issue 1-2, 2009, Pages 74-79

  Bakhiya, Nadiya ^a   Arlt, Volker M ^b   Bahn, Andrew ^c   Burckhardt, Gerhard ^c   Phillips, David H ^b   Glatt, Hansruedi ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Aristolochic acid; DNA adducts; Kidney proximal tubule; Organic anion transporters; Urothelial cancer

Indexed keywords

4 AMINOHIPPURIC ACID; ARISTOLOCHIC ACID; ESTRONE SULFATE; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3; ORGANIC ANION TRANSPORTER 4;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; DNA ADDUCT; EMBRYO; ENDOTHELIUM CELL; FEMALE; GENOTOXICITY; HUMAN; HUMAN CELL; KIDNEY CELL; KIDNEY PROXIMAL TUBULE; NEPHROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET CELL DESTRUCTION; TOXICOKINETICS;

ANIMALS; ARISTOLOCHIC ACIDS; CELLS, CULTURED; DNA ADDUCTS; EXTRACELLULAR SPACE; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; OOCYTES; ORGANIC ANION TRANSPORTERS; P-AMINOHIPPURIC ACID; PROBENECID; RENAL AGENTS; XENOPUS LAEVIS;

ARISTOLOCHIA; AVENA; XENOPUS LAEVIS;

EID: 69449105950     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2009.07.014     Document Type: Article

References (45)

1. Arlt V.M., Ferluga D., Stiborova M., Pfohl-Leszkowicz A., Vukelic M., Ceovic S., Schmeiser H.H., and Cosyns J.P. Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer?. Int. J. Cancer 101 (2002) 500-502
2. Arlt V.M., Pfohl-Leszkowicz A., Cosyns J., and Schmeiser H.H. Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy. Mutat. Res. 494 (2001) 143-150
3. Arlt V.M., Stiborova M., and Schmeiser H.H. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 17 (2002) 265-277
4. Arlt V.M., Stiborova M., vom Brocke J., Simoes M.L., Lord G.M., Nortier J.L., Hollstein M., Phillips D.H., and Schmeiser H.H. Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer. Carcinogenesis 28 (2007) 2253-2261
5. Arlt V.M., Wiessler M., and Schmeiser H.H. Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene. Carcinogenesis 21 (2000) 235-242
6. Bakhiya N., Batke M., Laake J., Monien B.H., Frank H., Seidel A., Engst W., and Glatt H.R. Directing role of organic anion transporters in the excretion of mercapturic acids of alkylated polycyclic aromatic hydrocarbons. Drug Metab. Dispos. 35 (2007) 1824-1831
7. Bakhiya N., Stephani M., Bahn A., Ugele B., Seidel A., Burckhardt G., and Glatt H.R. uptake of chemically reactive, DNA-damaging sulfuric acid esters into renal cells by human organic anion transporters. J. Am. Soc. Nephrol. 17 (2006) 1414-1421
8. Balachandran P., Wei F., Lin R.C., Khan I.A., and Pasco D.S. Structure activity relationships of aristolochic acid analogues: toxicity in cultured renal epithelial cells. Kidney Int. 67 (2005) 1797-1805
9. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. Carcinogenesis 18 (1997) 1063-1067
10. Burckhardt B.C., and Burckhardt G. Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev. Physiol. Biochem. Pharmacol. 146 (2003) 95-158
11. Burckhardt G., Bahn A., Bakhiya N., and Wolff N.A. Physiology and pathophysiology of renal organic anion transporters OAT1 and OAT3. Nova Acta Leopoldina 89 (2004) 131-137
12. Cosyns J.P. Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date. Drug Saf. 26 (2003) 33-48
13. Debelle F.D., Vanherweghem J.L., and Nortier J.L. Aristolochic acid nephropathy: a worldwide problem. Kidney Int. 74 (2008) 158-169
14. Depierreux M., Van Damme B., Vanden Houte K., and Vanherweghem J.L. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am. J. Kidney Dis. 24 (1994) 172-180
15. Dixon M. The determination of enzyme inhibitor constants. Biochem. J. 55 (1953) 170-171
16. Ekaratanawong S., Anzai N., Jutabha P., Miyazaki H., Noshiro R., Takeda M., Kanai Y., Sophasan S., and Endou H. Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J. Pharmacol. Sci. 94 (2004) 297-304
17. Gold L.S., and Slone T.H. Aristolochic acid, an herbal carcinogen, sold on the Web after FDA alert. N. Engl. J. Med. 349 (2003) 1576-1577
18. Grollman A.P., Shibutani S., Moriya M., Miller F., Wu L., Moll U., Suzuki N., Fernandes A., Rosenquist T., Medverec Z., Jakovina K., Brdar B., Slade N., Turesky R.J., Goodenough A.K., Rieger R., Vukelic M., and Jelakovic B. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 12129-12134
19. Hagos Y., Stein D., Ugele B., Burckhardt G., and Bahn A. Human renal organic anion transporter 4 operates as an asymmetric urate transporter. J. Am. Soc. Nephrol. 18 (2007) 430-439
20. IARC. Aristolochia species and aristolochic acids. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene (2002), International Agency for Research on Cancer, Lyon, France pp. 69-128
21. Kabanda A., Jadoul M., Lauwerys R., Bernard A., and van Ypersele de Strihou C. Low molecular weight proteinuria in Chinese herbs nephropathy. Kidney Int. 48 (1995) 1571-1576
22. Lebeau C., Arlt V.M., Schmeiser H.H., Boom A., Verroust P.J., Devuyst O., and Beauwens R. Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells. Kidney Int. 60 (2001) 1332-1342
23. Lebeau C., Debelle F.D., Arlt V.M., Pozdzik A., De Prez E.G., Phillips D.H., Deschodt-Lanckman M.M., Vanherweghem J.L., and Nortier J.L. Early proximal tubule injury in experimental aristolochic acid nephropathy: functional and histological studies. Nephrol. Dial. Transplant. 20 (2005) 2321-2332
24. Li Y., Liu Z., Guo X., Shu J., Chen Z., and Li L. Aristolochic acid I-induced DNA damage and cell cycle arrest in renal tubular epithelial cells in vitro. Arch. Toxicol. 80 (2006) 524-532
25. Liu Z., Hergenhahn M., Schmeiser H.H., Wogan G.N., Hong A., and Hollstein M. Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 2963-2968
26. Lord G.M., Hollstein M., Arlt V.M., Roufosse C., Pusey C.D., Cook T., and Schmeiser H.H. DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy. Am. J. Kidney Dis. 43 (2004) e11-17
27. Meinl W., Pabel U., Osterloh-Quiroz M., Hengstler J.G., and Glatt H.R. Human sulphotransferases are involved in the activation of aristolochic acids and are expressed in renal target tissue. Int. J. Cancer 118 (2006) 1090-1097
28. Nedelko T., Arlt V.M., Phillips D.H., and Hollstein M. TP53 mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy-associated tumours. Int. J. Cancer 15 (2009) 987-990
29. Nortier J.L., Deschodt-Lanckman M.M., Simon S., Thielemans N.O., de Prez E.G., Depierreux M.F., Tielemans C.L., Richard C., Lauwerys R.R., Bernard A.M., and Vanherweghem J.L. Proximal tubular injury in Chinese herbs nephropathy: monitoring by neutral endopeptidase enzymuria. Kidney Int. 51 (1997) 288-293
30. Nortier J.L., Martinez M.C., Schmeiser H.H., Arlt V.M., Bieler C.A., Petein M., Depierreux M.F., De Pauw L., Abramowicz D., Vereerstraeten P., and Vanherweghem J.L. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N. Engl. J. Med. 342 (2000) 1686-1692
31. Nortier J.L., and Vanherweghem J.L. Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). Toxicology 181-182 (2002) 577-580
32. Nortier J.L., and Vanherweghem J.L. For patients taking herbal therapy-lessons from aristolochic acid nephropathy. Nephrol. Dial. Transplant. 22 (2007) 1512-1517
33. Pezzuto J.M., Swanson S.M., Mar W., Che C.T., Cordell G.A., and Fong H.H. Evaluation of the mutagenic and cytostatic potential of aristolochic acid (3,4-methylenedioxy-8-methoxy-10-nitrophenanthrene-1-carboxylic acid) and several of its derivatives. Mutat. Res. 206 (1988) 447-454
34. 32P-postlabeling assay for DNA adducts. Nat. Protoc. 2 (2007) 2772-2781
35. Russel F.G., Masereeuw R., and van Aubel R.A. Molecular aspects of renal anionic drug transport. Annu. Rev. Physiol. 64 (2002) 563-594
36. Sato N., Takahashi D., Chen S.M., Tsuchiya R., Mukoyama T., Yamagata S., Ogawa M., Yoshida M., Kondo S., Satoh N., and Ueda S. Acute nephrotoxicity of aristolochic acids in mice. J. Pharm. Pharmacol. 56 (2004) 221-229
37. Schmeiser H.H., Bieler C.A., Wiessler M., van Ypersele de Strihou C., and Cosyns J.P. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res. 56 (1996) 2025-2028
38. Shibutani S., Dong H., Suzuki N., Ueda S., Miller F., and Grollman A.P. Selective toxicity of aristolochic acids I and II. Drug Metab. Dispos. 35 (2007) 1217-1222
39. Simoes M.L., Hockley S.L., Schwerdtle T., da Costa G.G., Schmeiser H.H., Phillips D.H., and Arlt V.M. Gene expression profiles modulated by the human carcinogen aristolochic acid I in human cancer cells and their dependence on TP53. Toxicol. Appl. Pharmacol. 232 (2008) 86-98
40. Stiborova M., Frei E., and Schmeiser H.H. Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid. Kidney Int. 73 (2008) 1209-1211
41. Stiborova M., Frei E., Sopko B., Sopkova K., Markova V., Lankova M., Kumstyrova T., Wiessler M., and Schmeiser H.H. Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase. Carcinogenesis 24 (2003) 1695-1703
42. Stiborova M., Schmeiser H.H., Breuer A., and Frei E. Evidence for activation of carcinogenic o-anisidine by prostaglandin H synthase: 32P-postlabelling analysis of DNA adduct formation. Gen. Physiol. Biophys. 20 (2001) 267-279
43. Sweet D.H. Organic anion transporter (Slc22a) family members as mediators of toxicity. Toxicol. Appl. Pharmacol. 204 (2005) 198-215
44. Takeda M., Narikawa S., Hosoyamada M., Cha S.H., Sekine T., and Endou H. Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters. Eur. J. Pharmacol. 419 (2001) 113-120
45. Vanherweghem J.L., Depierreux M., Tielemans C., Abramowicz D., Dratwa M., Jadoul M., Richard C., Vandervelde D., Verbeelen D., and Vanhaelen-Fastre R. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 341 (1993) 387-391